ISSN 1301 - 0883 / E-ISSN 1309 - 3886
 
 








  High immunogenicity of measles AIK-C vaccine produced in Vietnam [Eastern J Med]
Eastern J Med. 2011; 16(3): 199-207

High immunogenicity of measles AIK-C vaccine produced in Vietnam

Nguyen Dang Hien1, Le Thi Luan1, Nguyen Thuy Huong1, Nguyen Nu Anh Thukral1, Tran Hong Thuy1, Nguyen Xuan Hoa1, Le Quoc Hung1, Duan Huy Hau2, Dao Xuan Vin2, Dinh Hong Duong2, Shuzo Ishikawa3, Tomio Lee4, Tetsuo Nakayama5
1
2
3
4
5

The goal of measles elimination has been set for 2012 in the WHO Western Pacific Region. To achieve this goal, an enhanced immunization strategy is required, and measles vaccines have been provided through the Expanded Programme on Immunization (EPI) in Vietnam. A large quantity of vaccines should be supplied for a two-dose immunization schedule with a supplementary catch-up campaign. The live measles vaccine AIK-C strain was produced in Vietnam through technical transfer from the Kitasato Institute, Japan. PolyVac I was produced from bulk materials imported from Japan and PolyVac II from the AIK-C seed. Two clinical trials were conducted using three vaccines: PolyVac I, and II, and the EPI vaccine (Rouvax) for the control. A total of 160 subjects were examined for the immunogenicity of PolyVac I and 57 for that of the EPI vaccine. All subjects became sero-converted in PolyVac I groups for three different Lots, but 54 (94.7%; 88.9-100%) of 57 recipients of the EPI vaccine became sero-positive. For PolyVac II, 118 initially sero-negatives became sero-converted. Whereas, 107 (95.5%; 91.7-99.3%) of 112 initially sero-negatives in the EPI group showed sero-conversion. The mean titers of post-immunization sera of sero-converted subjects receiving PolyVac I and II were lower than that for the EPI vaccine. No significant difference was observed in the incidence of adverse clinical events. Essentially the same results were obtained using PolyVac I and II, showing higher sero-conversion rates than the EPI vaccine, and PolyVac measles AIK-C will be favorable in Vietnam and Southeast Asian countries.

Keywords: Live attenuated measles vaccine, clinical trial, technical transfer


Nguyen Dang Hien, Le Thi Luan, Nguyen Thuy Huong, Nguyen Nu Anh Thukral, Tran Hong Thuy, Nguyen Xuan Hoa, Le Quoc Hung, Duan Huy Hau, Dao Xuan Vin, Dinh Hong Duong, Shuzo Ishikawa, Tomio Lee, Tetsuo Nakayama. High immunogenicity of measles AIK-C vaccine produced in Vietnam. Eastern J Med. 2011; 16(3): 199-207


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
Copyright 2020 Eastern Journal of Medicine. All Rights Reserved.
Home        |        Contact
LookUs & OnlineMakale